Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
V Darbinyan, G Aslanyan, E Amroyan… - Nordic journal of …, 2007 - Taylor & Francis
The objective of this study was to assess the efficacy and safety of standardized extract SHR-
5 of rhizomes of Rhodiola rosea L. in patients suffering from a current episode of …
5 of rhizomes of Rhodiola rosea L. in patients suffering from a current episode of …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - academia.edu
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - kvinnomedicin.se
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - xn--kvinnohlsa-w5a.se
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - Citeseer
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - kvinnomedicin.se
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - scholar.archive.org
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - xn--kvinnohlsa-w5a.se
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
[PDF][PDF] Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
A PANOSSIAN - NORD J PSYCHIATRY, 2007 - medref.se
Study design The investigation was a double-blind, randomized, parallel-group evaluation
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
of SHR-5 extract vs. placebo. Male and female subjects, aged between 18 and 70 years and …
Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
V Darbinyan, G Aslanyan, E Amroyan, E Gabrielyan… - 2007 - pubmed.ncbi.nlm.nih.gov
The objective of this study was to assess the efficacy and safety of standardized extract SHR-
5 of rhizomes of Rhodiola rosea L. in patients suffering from a current episode of …
5 of rhizomes of Rhodiola rosea L. in patients suffering from a current episode of …